Bajaj Healthcare Ltd

Bajaj Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.273.15 on 16 Mar 2026, marking a significant downturn amid a six-day losing streak that has seen the stock shed 12.6% of its value. This fresh low underscores ongoing pressures on the micro-cap pharmaceutical company, which continues to underperform both its sector and the broader market indices.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.293 on 13 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and the broader market, reflecting persistent pressures on its valuation and market sentiment.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.300.6 on 12 Mar 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed both its sector and broader market indices, reflecting persistent pressures on its valuation and market sentiment.

Bajaj Healthcare Ltd’s shares declined sharply to a new 52-week low of Rs.306.75 on 9 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock underperformed its sector and broader market indices, reflecting persistent challenges in its financial performance and valuation metrics.

Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 09 March 2026, providing investors with the latest insights into the company’s performance and outlook.

Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 08 March 2026, providing investors with an up-to-date view of the company’s fundamentals, valuation, financial trends, and technical outlook.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.312.05 on 4 March 2026, marking a significant milestone in the stock’s downward trajectory amid broader market fluctuations and company-specific performance factors.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.317.9 on 2 March 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical and biotechnology company’s stock has underperformed its sector and broader market indices, reflecting a combination of financial headwinds and market pressures.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.329 on 27 Feb 2026, marking a continuation of the stock’s downward trajectory amid broader sectoral and market pressures. The stock has now underperformed significantly against benchmark indices over the past year, reflecting persistent challenges in its financial performance and valuation metrics.

Bajaj Healthcare Ltd’s shares declined sharply to a fresh 52-week low of Rs.329.05 on 26 Feb 2026, marking a significant downturn amid broader market gains. The stock underperformed its sector and key benchmarks, reflecting ongoing concerns over its financial trajectory and valuation metrics.

Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock's current position as of 25 February 2026, providing investors with the most up-to-date view of the company’s fundamentals, returns, and market performance.

Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed here reflect the stock’s current position as of 13 February 2026, providing investors with the most up-to-date view of the company’s performance and outlook.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.329.9 on 2 Feb 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has now recorded a three-day consecutive fall, cumulatively losing 8.19% over this period, reflecting persistent pressures amid broader market dynamics.

Bajaj Healthcare Ltd is rated Strong Sell by MarketsMOJO, with this rating last updated on 19 January 2026. However, the analysis and financial metrics discussed below reflect the company’s current position as of 02 February 2026, providing investors with the latest insights into its performance and outlook.

Bajaj Healthcare Ltd commenced trading today with a significant gap up, opening 7.78% higher than its previous close, signalling a robust start amid positive market sentiment. The stock outperformed its sector and broader market indices, maintaining momentum through a volatile session.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.336.25 on 27 Jan 2026, marking a significant milestone in the stock’s ongoing downward trajectory. The pharmaceutical company’s stock has now recorded a seven-day consecutive fall, accumulating a loss of 14.62% over this period, reflecting persistent pressures within the Pharmaceuticals & Biotechnology sector.

Bajaj Healthcare Ltd’s shares declined to a fresh 52-week low of Rs.355.75 on 23 Jan 2026, marking a significant downturn amid a six-day losing streak that has seen the stock shed 9.62% in value. This decline contrasts sharply with broader market trends, as the Sensex trades near its 52-week high, highlighting sector-specific pressures within the Pharmaceuticals & Biotechnology industry.